Pa. Rowlings et al., IBMTR SEVERITY INDEX FOR GRADING ACUTE GRAFT-VERSUS-HOST DISEASE - RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE, British Journal of Haematology, 97(4), 1997, pp. 855-864
Acute graft-versus-host disease (GVHD) severity is graded by pattern o
f organ involvement and clinical performance status using a system int
roduced by Glucksberg and colleagues 21 years ago. We examined how wel
l Glucksberg grade predicted transplant outcome and constructed a Seve
rity Index not requiring subjective assessment of performance in 2881
adults receiving an HLA-identical sibling T-cell-depIeted (n = 752) or
non-T-cell-depleted (n = 2123) bone marrow transplant for leukaemia b
etween 1986 and 1992. Relative risks (RR) of relapse, treatment-relate
d mortality (TRM) and treatment failure (TF) (relapse or death) were c
alculated for patients with Glucksberg Grade I, II or III/IV acute GVH
D Versus those without acute GVHD and for patients with distinct patte
rns of organ involvement regardless of Glucksberg grade. Using data fo
r non-T-cell-depleted transplants, a Severity Index was developed grou
ping patients with patterns of organ involvement associated with simil
ar risks of TRM and TF. Higher Glucksberg grade predicted poorer outco
me; however, patients with the same grade but different patterns of sk
in, liver or gut involvement often had significantly different outcome
s. The revised Severity Index groups patients in four categories, A-D.
Compared to patients without acute GVHD, RRs (95% confidence interval
) of TF were 0.85 (0.69, 1.05) for patients with Index A, 1.21 (1.02,
1.43) with B, 2.19 (1.78, 2.71) with C and 5.69 (4.57, 7.08) with D. P
rognostic utility of the Index was tested in patients receiving T-cell
-depleted transplants; similar RRs of TP were observed. An acute GVHD
Severity Index is proposed to enhance design and interpretation of cli
nical trials in the current era of allogeneic blood and bone marrow tr
ansplantation.